These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7851833)

  • 1. [Treatment of obesity as an insulin resistance].
    Ohashi M
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):323-5. PubMed ID: 7851833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.
    Rave K; Roggen K; Dellweg S; Heise T; tom Dieck H
    Br J Nutr; 2007 Nov; 98(5):929-36. PubMed ID: 17562226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension.
    Tekes S; Cikim AS
    J Hum Hypertens; 2007 Jul; 21(7):546-50. PubMed ID: 17392814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
    Ariza CR; Frati AC; Gómez G; Almazán A
    Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
    Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interconnection between insulin resistance and lipid metabolism disorders in obese patients].
    Ageeva VV; Krasil'nikova EI; Zubina IM; Shliakhto EV
    Ter Arkh; 2002; 74(10):12-5. PubMed ID: 12469622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children.
    Reinehr T; de Sousa G; Andler W
    Obes Res; 2005 Oct; 13(10):1824-33. PubMed ID: 16286531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
    de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
    Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
    Sindelka G; Skrha J; Hilgertová J; Justová V
    Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
    Lind L; Lithell H; Pollare T
    J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
    Brun JF; Aloulou I; Varlet-Marie E
    Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obesity and insulin resistance].
    Pandolfi C; Pellegrini L; Sbalzarini G; Mercantini F
    Minerva Med; 1994 Apr; 85(4):167-71. PubMed ID: 8028743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.